These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

126 related articles for article (PubMed ID: 15298532)

  • 21. A Markov model of the cost-effectiveness of pharmacist care for diabetes in prevention of cardiovascular diseases: evidence from Kaiser Permanente Northern California.
    Yu J; Shah BM; Ip EJ; Chan J
    J Manag Care Pharm; 2013 Mar; 19(2):102-14. PubMed ID: 23461426
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Evaluation of the economic and clinical impact of community pharmacist-driven pharmacy benefit management services.
    Jackson DL; Michaels NM; Melson B; Bruder E; Rhodes LA; Marciniak MW
    J Am Pharm Assoc (2003); 2019; 59(4S):S91-S94. PubMed ID: 31203015
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Addition of generic medication vouchers to a pharmacist academic detailing program: effects on the generic dispensing ratio in a physician-hospital organization.
    Bhargava V; Greg ME; Shields MC
    J Manag Care Pharm; 2010; 16(6):384-92. PubMed ID: 20635829
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Clinical and Economic Effects of a Pharmacist-Administered Antiretroviral Therapy Adherence Clinic for Patients Living with HIV.
    Dilworth TJ; Klein PW; Mercier RC; Borrego ME; Jakeman B; Pinkerton SD
    J Manag Care Spec Pharm; 2018 Feb; 24(2):165-172. PubMed ID: 29384024
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Utilization and drug cost outcomes of a step-therapy edit for generic antidepressants in an HMO in an integrated health system.
    Dunn JD; Cannon E; Mitchell MP; Curtiss FR
    J Manag Care Pharm; 2006 May; 12(4):294-302. PubMed ID: 16792435
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Effects of a physician office generic drug sampling system on generic dispensing ratios and drug costs in a large managed care organization.
    Scott AB; Culley EJ; O'Donnell J
    J Manag Care Pharm; 2007 Jun; 13(5):412-9. PubMed ID: 17605512
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Counter sampling combined with medical provider education: do they alter prescribing behavior?
    Erramouspe J; Bailey JM; Cleveland KW; Casperson K; Hunt TL; Cady PS
    Consult Pharm; 2006 Aug; 21(8):636-42. PubMed ID: 17076590
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Impact of clinical pharmacists' recommendations on a proton pump inhibitor taper protocol in an ambulatory care practice.
    Bundeff AW; Zaiken K
    J Manag Care Pharm; 2013 May; 19(4):325-33. PubMed ID: 23627578
    [TBL] [Abstract][Full Text] [Related]  

  • 29. A sustainable business model for comprehensive medication management in a patient-centered medical home.
    Fabel PH; Wagner T; Ziegler B; Fleming PA; Davis RE
    J Am Pharm Assoc (2003); 2019; 59(2):285-290. PubMed ID: 30611660
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The PRICE clinic for low-income elderly: a managed care model for implementing pharmacist-directed services.
    Stebbins MR; Kaufman DJ; Lipton HL
    J Manag Care Pharm; 2005 May; 11(4):333-41. PubMed ID: 15871644
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Effect of a therapeutic maximum allowable cost (MAC) program on the cost and utilization of proton pump inhibitors in an employer-sponsored drug plan in Canada.
    Mabasa VH; Ma J
    J Manag Care Pharm; 2006 Jun; 12(5):371-6. PubMed ID: 16792443
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Comparison of mail-order with community pharmacy in plan sponsor cost and member cost in two large pharmacy benefit plans.
    Johnsrud M; Lawson KA; Shepherd MD
    J Manag Care Pharm; 2007 Mar; 13(2):122-34. PubMed ID: 17330973
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Cost and utilization of behavioral health medications associated with rescission of an exemption for prior authorization for severe and persistent mental illness in the Vermont Medicaid Program.
    Simeone JC; Marcoux RM; Quilliam BJ
    J Manag Care Pharm; 2010 Jun; 16(5):317-28. PubMed ID: 20518584
    [TBL] [Abstract][Full Text] [Related]  

  • 34. A bitter pill: formulary variability and the challenge to prescribing physicians.
    Shrank WH; Ettner SL; Glassman P; Asch SM
    J Am Board Fam Pract; 2004; 17(6):401-7. PubMed ID: 15575031
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Medication cost information in a computer-based patient record system. Impact on prescribing in a family medicine clinical practice.
    Ornstein SM; MacFarlane LL; Jenkins RG; Pan Q; Wager KA
    Arch Fam Med; 1999; 8(2):118-21. PubMed ID: 10101981
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Advanced Practice Pharmacists: a retrospective evaluation of the efficacy and cost of ClinicaL Pharmacist PractitionErs managing ambulatory Medicare patients in North Carolina (APPLE-NC).
    Kislan MM; Bernstein AT; Fearrington LR; Ives TJ
    BMC Health Serv Res; 2016 Oct; 16(1):607. PubMed ID: 27769219
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Medication review and patient counselling at discharge from the hospital by community pharmacists.
    Hugtenburg JG; Borgsteede SD; Beckeringh JJ
    Pharm World Sci; 2009 Dec; 31(6):630-7. PubMed ID: 19649720
    [TBL] [Abstract][Full Text] [Related]  

  • 38. ACE Inhibitor and ARB utilization and expenditures in the Medicaid fee-for-service program from 1991 to 2008.
    Bian B; Kelton CM; Guo JJ; Wigle PR
    J Manag Care Pharm; 2010; 16(9):671-9. PubMed ID: 21067253
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Do doctors in dispensing practices with a financial conflict of interest prescribe more expensive drugs? A cross-sectional analysis of English primary care prescribing data.
    Goldacre B; Reynolds C; Powell-Smith A; Walker AJ; Yates TA; Croker R; Smeeth L
    BMJ Open; 2019 Feb; 9(2):e026886. PubMed ID: 30813120
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Specialty pharmacies and other restricted drug distribution systems: financial and safety considerations for patients and health-system pharmacists.
    Kirschenbaum BE
    Am J Health Syst Pharm; 2009 Dec; 66(24 Suppl 7):S13-20. PubMed ID: 19966075
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.